Antipodes Partners LTD Bruker Corp Transaction History
Antipodes Partners LTD
- $4.06 Billion
- Q3 2025
A detailed history of Antipodes Partners LTD transactions in Bruker Corp stock. As of the latest transaction made, Antipodes Partners LTD holds 8,168 shares of BRKR stock, worth $339,952. This represents 0.01% of its overall portfolio holdings.
Number of Shares
8,168
Previous 6,788
20.33%
Holding current value
$339,952
Previous $279,000
5.02%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding BRKR
# of Institutions
385Shares Held
118MCall Options Held
543KPut Options Held
488K-
Orbis Allan Gray LTD Hamilton, D014.1MShares$589 Million2.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.4MShares$433 Million0.01% of portfolio
-
Black Rock Inc. New York, NY9.83MShares$409 Million0.01% of portfolio
-
Pallas Capital Advisors LLC Braintree, MA9.48MShares$395 Million14.57% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.38MShares$266 Million0.13% of portfolio
About BRUKER CORP
- Ticker BRKR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 148,138,000
- Market Cap $6.17B
- Description
- Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, ...